| 000 | 00864 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250512211922.0 | ||
| 264 | 0 | _c19840817 | |
| 008 | 198408s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBowers, L D | |
| 245 | 0 | 0 |
_aCyclosporine: experience with therapeutic monitoring. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _c1984 |
||
| 300 |
_a142-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChemical Phenomena |
| 650 | 0 | 4 | _aChemistry |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aCyclosporins _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 700 | 1 | _aCanafax, D M | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 6 _gno. 2 _gp. 142-7 |
|
| 999 |
_c6377507 _d6377507 |
||